These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15726724)

  • 1. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
    Colker AC
    NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
    [No Abstract]   [Full Text] [Related]  

  • 2. Removal of thresholds for the List I chemicals pseudoephedrine and phenylpropanolamine. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2010 Jul; 75(129):38915-22. PubMed ID: 20608288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information on foreign chain of distribution for ephedrine, pseudoephedrine, and phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Mar; 75(43):10168-72. PubMed ID: 20383917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 7. Import and production quotas for certain List I chemicals. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2007 Jul; 72(131):37439-53. PubMed ID: 17674492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retail sales of scheduled listed chemical products; self-certification of regulated sellers of scheduled listed chemical products. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2006 Sep; 71(186):56008-27. PubMed ID: 17017470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooking up solutions to a cooked up menace: responses to methamphetamine in a federal system.
    Harv Law Rev; 2006 Jun; 119(8):2508-29. PubMed ID: 16827221
    [No Abstract]   [Full Text] [Related]  

  • 11. Pseudoephedrine laws in the US--are we doing enough?
    Murty S; Sansgiry SS
    Ann Pharmacother; 2006 Jun; 40(6):1213-5. PubMed ID: 16735651
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-certification and employee training of mail-order distributors of scheduled listed chemical products. Interim final rule with request for comment.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2011 Apr; 76(71):20518-24. PubMed ID: 21491808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The holy grail of supply control: have we found the evidence?
    McKetin R
    Addiction; 2009 Mar; 104(3):455-6. PubMed ID: 19207355
    [No Abstract]   [Full Text] [Related]  

  • 15. How to expand the 'sample size' of studies of drug market disruptions.
    Caulkins J
    Addiction; 2009 Mar; 104(3):454-5. PubMed ID: 19207354
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions.
    Cunningham JK; Liu LM
    Addiction; 2003 Sep; 98(9):1229-37. PubMed ID: 12930210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists on the front lines in the fight against meth. A 50-state comparison of the laws regulating the retail sale of pseudoephedrine.
    Rigdon BA
    J Leg Med; 2012 Apr; 33(2):253-83. PubMed ID: 22694096
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States.
    Cunningham JK; Liu LM; Callaghan R
    Addiction; 2009 Mar; 104(3):441-53. PubMed ID: 19207353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exemption of chemical mixtures containing the List I chemicals ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and pseudoephedrine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 May; 68(84):23195-206. PubMed ID: 12725239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.